Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs

Iambic’s latest financing follows the presentation of data for its breast cancer drug during the recent European Society of Medical Oncology conference. Our financing roundup includes capital raised by startups developing novel therapies immunology, metabolic disorders, genetic diseases, and more. The post Startup Iambic Raises $100M for Clinical Trials of AI-Discovered Cancer Drugs appeared first…

Read More

Late-in-Life Autism Diagnosis: Why Adults Still Face So Many Barriers and How We Can Do Better

Awareness of autism has grown, but we need to move beyond this into understanding and acceptance. Real progress depends on how we translate understanding into action — training more professionals, funding adult services, and redesigning workplaces and communities so autistic individuals can flourish throughout their lifespan. The post Late-in-Life Autism Diagnosis: Why Adults Still Face…

Read More

What Excites Zimmer Biomet’s CIO About MedTech Right Now?

Shaun Braun, Zimmer Biomet’s chief information and technology officer, said today’s biggest medtech innovation is the field’s focus on connection and interoperability. By integrating data, AI and robotics into a single ecosystem, the company is seeking to deliver more personalized care and improve surgical outcomes. The post What Excites Zimmer Biomet’s CIO About MedTech Right…

Read More